analysis to have a novel pentacyclic 3H-naphtho[1′,8′a:5,6]-
pyrano[2,3-e]isoindol-3-one skeleton (ABCDE ring system)
with five asymmetric carbons,1a,b in which cis-fused AB rings
and BC rings and an ether bond at the bridgehead of the AB
ring junction are particularly characteristic features. The
absolute configuration of 1 was determined by its circular
dichroism (CD) spectrum as depicted in Figure 1.1b
tetracyclic cores 2 and 3, respectively, in one step, where
we envisioned that this acid-induced domino reaction would
proceed stereoselectively to install the requisite cis-fused AB
ring junction (cf. 5f[IfIIfIII]f3, Scheme 3). To the best
of our knowledge, this domino sequence is hitherto unknown,
and hence it involves an interesting possibility at a synthetic
chemical level. The cyclized compound 3 having the
epimeric C3 R-hydroxy group would be converted to target
compound 2 through inversion of the C3 hydroxy group.
Epoxides 4 and 5, in turn, would be elaborated from
intermediate 6 by sequential manipulation of the C4 exo-
olefin moiety and deprotection of the phenolic O-methyl
group, or vice versa. Intermediate 6, which possesses the
trans-fused decalin system, would be prepared through the
stereocontrolled reductive alkylation of the known enone 711
with the known bromide 812 applying the related protocols
previously described in the literature.13
At first, as shown in Scheme 2, we pursued the synthesis
of epoxides 4 and 5, precursors of the key acid-induced
domino reaction. The synthesis commenced with the reduc-
tive alkylation of the known enantiomerically pure enone
711 (>99% ee) with 2-methoxybenzyl bromide (8),12 readily
prepared from commercially available 2-methoxybenzyl
alcohol. Thus, reduction of the enone 7 by treatment with
lithium (3 equiv) in liquid ammonia, followed by trapping
the intermediary lithium enolate through reaction with the
bromide 8 (6 equiv), furnished the expected coupling product
9 as the sole diastereomer in 72% yield. Subsequent Wittig
methylenation of the sterically hindered carbonyl group in
9 was best achieved by employing a combination of
methyltriphenylphosphonium bromide and potassium tert-
butoxide14 in refluxing benzene, providing exo-olefin 10 in
86% yield.
Its remarkable biological properties as well as its unique
structural features make 1 an exceptionally intriguing and
timely target for total synthesis. To date, only one total
synthesis of racemic (()-1 has been reported by Mori et al.
at Shionogi & Co., Ltd., in 1998,8 wherein the ABCDE ring
system was built step-by-step starting from 2,3-dimethyl-
cyclohexanone, which corresponds to the B ring of 1. We
embarked on a project directed at the total synthesis of
optically active (+)-1 and its analogues with the aim of
exploring structure-activity relationships.9 In this Letter, we
report our preliminary results concerning a highly concise
method for the synthesis of model compound 2, which
represents the tetracyclic core structure (ABCD ring system)
having the requisite substituents and asymmetric carbons
contained in 1.
The synthetic plan for the tetracyclic core 2 is outlined in
Scheme 1, which was designed on the basis of our previous
Scheme 1. Synthetic Plan for the Tetracyclic Core 2
For elaborating the C8 stereocenter, the ethylene acetal
moiety in 10 was first removed by acid treatment (97%),
and the resulting ketone derivative 11 was subjected to
hydrogenation (1 atm) over 10% Pd/C in 50:1 triethylamine-
methanol at ambient temperature, which afforded a mixture
of diastereomers that were separated by column chromatog-
(6) Hayden, F. G.; Osterhaus, A. D.; Treanor, J. J.; Fleming, D. M.;
Aoki, F. Y.; Nicholson, K. G.; Bohnen, A. M.; Hirst, H. M.; Keene, O.;
Wightman, K. N. Engl. J. Med. 1997, 337, 874.
(7) Lew, W.; Chen, X.; Kim, C. U. Curr. Med. Chem. 2000, 7, 663.
(8) Taishi, T.; Takechi, S.; Mori, S. Tetrahedron Lett. 1998, 39, 4347.
(9) Preliminary structure-activity studies of stachyflin derivatives have
been performed by the Shionogi research group; see ref 1c.
(10) Nakamura, M., Suzuki, A.; Nakatani, M.; Fuchikami, T.; Inoue, M.;
Katoh, T. Tetrahedron Lett. 2002, 43, 6929.
(11) Hagiwara, H.; Uda, H. J. Org. Chem. 1988, 53, 2308.
(12) Kelly, J. L.; Linn, J. A.; Selway, J. W. T. J. Med. Chem. 1989, 32,
1757.
work.10 The key feature in this plan is a biogenetic-type acid-
induced domino epoxide-opening/rearrangement/cyclization
reaction of epoxides 4 and 5 to construct the desired
(13) This type of reductive alkylation, originally developed by Stork et
al. in the 1960s, has been widely utilized as a critical step in the total
synthesis of marine sesquiterpene quinones and hydroquinones. For recent
examples, see: (a) Ling, T.; Poupon, E.; Rueden, E. J.; Kim, S. H.;
Theodorakis, E. A. J. Am. Chem. Soc. 2002, 124, 12261. (b) Stahl, P.;
Kissau, L.; Mazitschek, R.; Huwe, A.; Furet, P.; Giannis, A.; Waldmann,
H. J. Am. Chem. Soc. 2001, 123, 11586. (c) Poigny, S.; Guyot, M.; Samadi,
M. J. Org. Chem. 1998, 63, 5890. (d) Locke, E. P.; Hecht, S. M. Chem.
Commun. 1996, 2717. (e) An, J.; Wiemer, D. F. J. Org. Chem. 1996, 61,
8775. (f) Bruner, S. D.; Radeke, H. S.; Tallarico, J. A.; Snapper, M. L. J.
Org. Chem. 1995, 60, 1114. (g) Sarma, A. S.; Chattopadhyay, P. J. Org.
Chem. 1982, 47, 1727.
(3) In addition to the in vitro activity, the in vivo anti-influenza virus
activity of stachyflin (1) and its derivatives was also extensively studied
by the Shionogi research group; see: (a) Yoshimoto, J.; Yagi, S.; Ono, J.;
Sugita, K.; Hattori, N.; Fujioka, T.; Fujiwara, T.; Sugimoto, H.; Hashimoto,
N. J. Pharm. Pharmacol. 2000, 52, 1247. (b) Yagi, S.; Ono, J.; Yoshimoto,
J.; Sugita, K.; Hattori, N.; Fujioka, T.; Fujiwara, T.; Sugimoto, H.; Hirano,
K.; Hashimoto, N. Pharm. Res. 1999, 16, 1041.
(4) (a) Yoshimoto, J.; Kakui, M.; Iwasaki, H.; Sugimoto, H.; Fujiwara,
T.; Hattori, N. Microbiol. Immunol. 2000, 44, 677. (b) Yoshimoto, J.; Kakui,
M.; Iwasaki, H.; Fujiwara, T.; Sugimoto, H.; Hattori, N. Arch. Virol. 1999,
144, 865.
(14) This reagent system is known to be effective for sterically hindered
ketones; see: Fitjer, L.; Quabeck, U. Synth. Commun. 1985, 15, 855.
(5) Pinto, L. H.; Holsinger, L. J.; Lamb, R. A. Cell 1992, 69, 517.
4484
Org. Lett., Vol. 4, No. 25, 2002